Qinghai Spring Medicinal Resources Technology Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.07%

Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has an Asset Resilience Ratio of 0.07% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 600381 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥745.99K

≈ $109.16K USD Cash + Short-term Investments

Total Assets

CN¥1.08 Billion

≈ $158.02 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2024)

This chart shows how Qinghai Spring Medicinal Resources Technology Co Ltd's Asset Resilience Ratio has changed over time. See Qinghai Spring Medicinal Resources Techn (600381) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Qinghai Spring Medicinal Resources Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Qinghai Spring Medicinal Resources Techn market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥745.99K	0.07%
Total Liquid Assets	CN¥745.99K	0.07%

Asset Resilience Insights

Limited Liquidity: Qinghai Spring Medicinal Resources Technology Co Ltd maintains only 0.07% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Qinghai Spring Medicinal Resources Technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Qinghai Spring Medicinal Resources Technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Qinghai Spring Medicinal Resources Technology Co Ltd (2005–2024)

The table below shows the annual Asset Resilience Ratio data for Qinghai Spring Medicinal Resources Technology Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.06%	CN¥742.73K ≈ $108.68K	CN¥1.16 Billion ≈ $170.37 Million	+0.01pp
2023-12-31	0.05%	CN¥670.29K ≈ $98.08K	CN¥1.36 Billion ≈ $198.91 Million	+0.01pp
2022-12-31	0.04%	CN¥656.75K ≈ $96.10K	CN¥1.56 Billion ≈ $228.16 Million	-1.83pp
2021-12-31	1.87%	CN¥34.65 Million ≈ $5.07 Million	CN¥1.85 Billion ≈ $270.44 Million	+0.44pp
2020-12-31	1.43%	CN¥31.63 Million ≈ $4.63 Million	CN¥2.21 Billion ≈ $322.83 Million	-1.10pp
2019-12-31	2.53%	CN¥61.00 Million ≈ $8.93 Million	CN¥2.41 Billion ≈ $352.48 Million	-6.11pp
2018-12-31	8.65%	CN¥210.58 Million ≈ $30.81 Million	CN¥2.44 Billion ≈ $356.39 Million	-11.89pp
2017-12-31	20.54%	CN¥499.72 Million ≈ $73.13 Million	CN¥2.43 Billion ≈ $356.09 Million	-6.83pp
2016-12-31	27.37%	CN¥605.06 Million ≈ $88.54 Million	CN¥2.21 Billion ≈ $323.50 Million	+2.29pp
2015-12-31	25.08%	CN¥530.00 Million ≈ $77.56 Million	CN¥2.11 Billion ≈ $309.20 Million	+21.24pp
2005-12-31	3.84%	CN¥52.70 Million ≈ $7.71 Million	CN¥1.37 Billion ≈ $200.90 Million	--

pp = percentage points

About Qinghai Spring Medicinal Resources Technology Co Ltd

SHG:600381 China Drug Manufacturers - Specialty & Generic

Market Cap

$308.40 Million

CN¥2.11 Billion CNY

Market Cap Rank

#14840 Global

#4588 in China

Share Price

CN¥3.59

Change (1 day)

+4.97%

52-Week Range

CN¥2.61 - CN¥5.58

All Time High

CN¥24.91